The Current Ratio as of November 2024 (TTM) for Cytek Biosciences, Inc. (CTKB) is 6.21

According to Cytek Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.21. This represents a change of -9.67% compared to the average of 6.88 of the last 4 quarters.

Cytek Biosciences, Inc. (CTKB) Historical Current Ratio (quarterly & annually)

How has CTKB Current Ratio performed in the past?

The mean historical Current Ratio of Cytek Biosciences, Inc. over the last ten years is 8.15. The current 6.21 Current Ratio has changed 7.52% with respect to the historical average. Over the past ten years (40 quarters), CTKB's Current Ratio was at its highest in in the September 2021 quarter at 14.74. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Cytek Biosciences, Inc. (CTKB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cytek Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytek Biosciences, Inc. (CTKB) Average Current Ratio

How has CTKB Current Ratio performed in the past?

The current Current Ratio of Cytek Biosciences, Inc. (CTKB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cytek Biosciences, Inc. (CTKB) Current Ratio vs. Peers

How is CTKB’s Current Ratio compared to its peers?

Cytek Biosciences, Inc.’s Current Ratio is less than Heska Corporation (6.70), less than OrthoPediatrics Corp. (7.17), greater than Electromed, Inc. (5.53), less than Pulmonx Corporation (7.70), less than RxSight, Inc. (12.67), greater than AxoGen, Inc. (3.74), greater than Treace Medical Concepts, Inc. (4.12), greater than Orthofix Medical Inc. (2.39), greater than NeuroPace, Inc. (5.59), greater than Inogen, Inc. (2.66), greater than Surmodics, Inc. (3.96), greater than Apyx Medical Corporation (5.46), greater than ProSomnus, Inc. Common Stock (0.30), greater than LivaNova PLC (3.37), less than Sight Sciences, Inc. (10.18), greater than STRATA Skin Sciences, Inc. (1.13), greater than Vapotherm, Inc. (0.25), less than Talis Biomedical Corporation (7.76),

Build a custom stock screener for Cytek Biosciences, Inc. (CTKB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytek Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytek Biosciences, Inc. (CTKB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytek Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.